[go: up one dir, main page]

GB9216155D0 - Treatment of dentoalveolar infections - Google Patents

Treatment of dentoalveolar infections

Info

Publication number
GB9216155D0
GB9216155D0 GB929216155A GB9216155A GB9216155D0 GB 9216155 D0 GB9216155 D0 GB 9216155D0 GB 929216155 A GB929216155 A GB 929216155A GB 9216155 A GB9216155 A GB 9216155A GB 9216155 D0 GB9216155 D0 GB 9216155D0
Authority
GB
United Kingdom
Prior art keywords
treatment
dentoalveolar
infections
dentoalveolar infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929216155A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Priority to GB929216155A priority Critical patent/GB9216155D0/en
Publication of GB9216155D0 publication Critical patent/GB9216155D0/en
Priority to PCT/GB1993/001607 priority patent/WO1994003174A1/fr
Priority to EP93917947A priority patent/EP0652753A1/fr
Priority to CA002141056A priority patent/CA2141056C/fr
Priority to JP6505094A priority patent/JPH07509483A/ja
Priority to US09/345,744 priority patent/US6488912B1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
GB929216155A 1992-07-30 1992-07-30 Treatment of dentoalveolar infections Pending GB9216155D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB929216155A GB9216155D0 (en) 1992-07-30 1992-07-30 Treatment of dentoalveolar infections
PCT/GB1993/001607 WO1994003174A1 (fr) 1992-07-30 1993-07-29 Traitement d'infections dento-alveolaires avec la taurolidine et/ou le taurultam
EP93917947A EP0652753A1 (fr) 1992-07-30 1993-07-29 Traitement d'infections dento-alveolaires avec la taurolidine et/ou le taurultam
CA002141056A CA2141056C (fr) 1992-07-30 1993-07-29 Traitement contre les infections dentoalveolaires au moyen de taurolidine et (ou) de taurultam
JP6505094A JPH07509483A (ja) 1992-07-30 1993-07-29 歯と歯槽の感染の処置
US09/345,744 US6488912B1 (en) 1992-07-30 1999-07-01 Treatment of dentoalveolar infections with taurolidine and/or taurultam

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216155A GB9216155D0 (en) 1992-07-30 1992-07-30 Treatment of dentoalveolar infections

Publications (1)

Publication Number Publication Date
GB9216155D0 true GB9216155D0 (en) 1992-09-09

Family

ID=10719520

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929216155A Pending GB9216155D0 (en) 1992-07-30 1992-07-30 Treatment of dentoalveolar infections

Country Status (5)

Country Link
EP (1) EP0652753A1 (fr)
JP (1) JPH07509483A (fr)
CA (1) CA2141056C (fr)
GB (1) GB9216155D0 (fr)
WO (1) WO1994003174A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1160115C (zh) * 1994-12-12 2004-08-04 奥默罗斯公司 用于抑制疼痛,炎症和痉挛的冲洗液和方法
AU4467396A (en) * 1994-12-12 1996-07-10 Omeros Medical Systems, Inc. Irrigation solution and method for inhibition of pain, inflammation and spasm
KR100517210B1 (ko) * 1994-12-12 2006-06-07 오메로스 코포레이션 통증,염증및경련억제용관주용액
CA2265774C (fr) * 1996-06-24 2009-05-05 Bio-Safe Enterprises, Inc. Composition antibacterienne
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
CA2393252A1 (fr) * 1999-12-06 2001-06-07 Paul Calabresi Utilisation de composes renfermant du methylol pour traiter des tumeurs
CN100519525C (zh) 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
EP1797884B1 (fr) * 1999-12-06 2013-09-11 Geistlich Pharma AG Taurolidine ou de taurultame pour i' utilisation dans le traitement des tumeurs de la prostate, des poumons, du côlon et dans le traitement de la glioblastome multiforme récurrente
WO2003028642A2 (fr) 2001-10-01 2003-04-10 Rhode Island Hospital, A Lifespan Partner Procede d'inhibition de metastases
DE10261241A1 (de) * 2002-12-20 2004-07-15 3M Espe Ag Dentalmaterial mit bakteriostatischen und/oder bakteriziden Substanzen
ATE354380T1 (de) * 2003-02-03 2007-03-15 Polaschegg Hans-Dietrich Dr Te Zusammensetzung zur prävention von infektionen durch subkutane prothesen
JP2007537200A (ja) * 2004-05-14 2007-12-20 ハンス−ディートリヒ・ポラシェグ タウロリジン製剤及び投与：細菌マイクロフィルム形成に対する治療処置及び抗菌保護
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
EP1787627A1 (fr) 2005-11-17 2007-05-23 3M Innovative Properties Company Materiau d`empreinte dentaire antimicrobien
CA2812845A1 (fr) * 2010-09-27 2012-04-05 Geistlich Pharma Ag Preparation de soins dentaires antimicrobienne
US20170100407A1 (en) * 2015-10-07 2017-04-13 Cormedix Inc. Skin-penetrating formulation of taurolidine
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH600878A5 (fr) * 1975-04-28 1978-06-30 Gaba Ag
GB1557163A (en) * 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
GB8328073D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
EP0521225B1 (fr) * 1991-07-04 1994-10-12 Hawe Neos Dental Dr. H. v. Weissenfluh SA Compositions pharmaceutiques pour le traitement de la parodontose, contenant l'acide clavulanique

Also Published As

Publication number Publication date
CA2141056C (fr) 2005-02-15
WO1994003174A1 (fr) 1994-02-17
CA2141056A1 (fr) 1994-02-17
EP0652753A1 (fr) 1995-05-17
JPH07509483A (ja) 1995-10-19

Similar Documents

Publication Publication Date Title
GB9215633D0 (en) Novel treatment
GB9216155D0 (en) Treatment of dentoalveolar infections
ZA933519B (en) Treatment of wastewater
GB9226860D0 (en) Novel treatment
EP0559791A4 (en) Treatment of topical infections
GB2269164B (en) Treatment of polyvinylchloride
GB9304746D0 (en) Treatment of viral infections
GB9211148D0 (en) Novel treatment
GB9225860D0 (en) Novel treatment
GB9226957D0 (en) Novel treatment
GB9211736D0 (en) Allergic treatment
GB2283485B (en) Treatment of sludge
GB9419692D0 (en) Treatment of herpes infections
GB9226958D0 (en) Produktionsaktieselskab) novel treatment
GB9218027D0 (en) Novel method of treatment
ZA923125B (en) Treatment of mastitis
AP9300527A0 (en) Novel treatment
ZA93491B (en) Treatment of psychoses
GB9203637D0 (en) Novel treatment
GB9225859D0 (en) Novel treatment
ZW11693A1 (en) Method of treating viral infections
GB9212535D0 (en) Treatment of boimass
ZA941471B (en) Treatment of viral infections
GB9310882D0 (en) Allergic treatment
GB9125670D0 (en) Treatment of neurogical conditions